Michael Barbella, Managing Editor04.01.22
Channel Medsystems Inc. has recruited a new member to join its Board of Directors.
Lisa Garrett is now a part of the governing body. She is an experienced finance and human resources executive with more than 20 years of experience in the pharmaceutical and medical technology industries. She has served as chief financial officer (CFO) for various privately funded research and commercial organizations, where she contributed to raising more than $150 million dollars in equity and debt financings. Most recently, Garrett was CFO of Cardiva Medical Inc. which was acquired by Haemonetics in 2021. Previously she held senior leadership positions at ForSight VISION5, Corventis Inc., Sybase Inc., Guidant Corporation, and Eli Lilly & Company.
“I’m thrilled to have the opportunity to contribute to critical advancements in women’s healthcare,” said Garrett. “Channel’s Cerene Cryotherapy Device will help treat women suffering from heavy menstrual bleeding and better serve gynecologists and their patients in the office setting.”
“Lisa brings a wealth of financial leadership experience at large and emerging companies in the healthcare industry,” CEO Ric Cote said. “We’re excited to welcome her to the board of directors, and I know that all of us will benefit from her leadership, expertise and experience.”
Channel Medsystems is a privately-held company develops treatments to meet the needs of female patients. The firm is based in Berkeley, Calif.
Lisa Garrett is now a part of the governing body. She is an experienced finance and human resources executive with more than 20 years of experience in the pharmaceutical and medical technology industries. She has served as chief financial officer (CFO) for various privately funded research and commercial organizations, where she contributed to raising more than $150 million dollars in equity and debt financings. Most recently, Garrett was CFO of Cardiva Medical Inc. which was acquired by Haemonetics in 2021. Previously she held senior leadership positions at ForSight VISION5, Corventis Inc., Sybase Inc., Guidant Corporation, and Eli Lilly & Company.
“I’m thrilled to have the opportunity to contribute to critical advancements in women’s healthcare,” said Garrett. “Channel’s Cerene Cryotherapy Device will help treat women suffering from heavy menstrual bleeding and better serve gynecologists and their patients in the office setting.”
“Lisa brings a wealth of financial leadership experience at large and emerging companies in the healthcare industry,” CEO Ric Cote said. “We’re excited to welcome her to the board of directors, and I know that all of us will benefit from her leadership, expertise and experience.”
Channel Medsystems is a privately-held company develops treatments to meet the needs of female patients. The firm is based in Berkeley, Calif.